Cystic fibrosis radiographic biomarkers - Commentary.
US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Division of Pulmonary, Allergy, and Rheumatology Products, United States. Electronic address: Anthony.Durmowicz@fda.hhs.gov.
Anthony G
AG
Durmowicz
D015415:Biomarkers; D003550:Cystic Fibrosis; D006801:Humans
D015415:Biomarkers